Evodiamine

CAS: 518-17-2

Ref. 3D-FE09940

Informação sobre produto

• Nome: Evodiamine
• Sinónimos: (13bS)-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, (13bS)-8,13,13b,14-Tetrahydro-14-methylindolo[2′,3′:3,4]pyrido[2,1-b]quinazolin-5(7H)-one, 14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, Evodiaminel, Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-, Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-, Indolo[2′,3′:3,4]pyrido[2,1-b]quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-, Indolo[2′,3′:3,4]pyrido[2,1-b]quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-, d-Evodiamine
• CAS: 518-17-2

Descrição

Evodiamine is a natural compound with apoptotic activity. It has been found to induce apoptosis in human osteosarcoma cells by binding to pro-apoptotic protein, leading to the activation of caspases and downregulation of Bcl-2. Evodiamine also has synergistic effects with other drugs that induce apoptosis, such as dextran sulfate, an anticancer drug. This compound has shown promising results in clinical trials for breast cancer and resistant breast cancer. The mechanism of action of evodiamine is not fully understood but it may involve autophagy or the induction of plate test. Evodiamine may also have anti-infectious properties due to its ability to inhibit bacteria growth by interfering with DNA binding activity and protein synthesis.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 303.36 g/mol
• Fórmula: C₁₉H₁₇N₃O
• Pureza: Min. 95%
• Cor/forma: Powder
• InChI: InChI=1S/C19H17N3O/c1-21-16-9-5-3-7-14(16)19(23)22-11-10-13-12-6-2-4-8-15(12)20-17(13)18(21)22/h2-9,18,20H,10-11H2,1H3/t18-/m0/s1
• Chave InChI: InChIKey=TXDUTHBFYKGSAH-SFHVURJKSA-N
• SMILES: CN1c2ccccc2C(=O)N2CCc3c([nH]c4ccccc34)[C@H]21